Israel Englander Oncternal Therapeutics, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.28 - $0.64 $115,087 - $263,057	411,028 Added 24.99%	2,055,904 $1.11 Million
Q2 2023 Aug 14, 2023	BUY	$0.28 - $0.79 $41,811 - $117,968	149,327 Added 9.98%	1,644,876 $559,000
Q1 2023 May 15, 2023	BUY	$0.63 - $1.3 $211,556 - $436,545	335,804 Added 28.95%	1,495,549 $1.17 Million
Q4 2022 Feb 14, 2023	BUY	$0.86 - $22.2 $494,362 - $12.8 Million	574,840 Added 98.28%	1,159,745 $1.16 Million
Q3 2022 Nov 14, 2022	SELL	$0.83 - $17.8 $590,304 - $12.7 Million	-711,210 Reduced 54.87%	584,905 $522,000
Q2 2022 Aug 15, 2022	BUY	$0.7 - $1.56 $592,193 - $1.32 Million	845,991 Added 187.95%	1,296,115 $1.44 Million
Q1 2022 May 16, 2022	BUY	$1.37 - $2.43 $57,341 - $101,707	41,855 Added 10.25%	450,124 $626,000
Q4 2021 Feb 14, 2022	BUY	$2.27 - $4.39 $203,416 - $393,392	89,611 Added 28.12%	408,269 $927,000
Q3 2021 Nov 15, 2021	BUY	$3.37 - $4.76 $554,341 - $782,986	164,493 Added 106.7%	318,658 $1.33 Million
Q2 2021 Aug 16, 2021	SELL	$4.75 - $9.39 $1.15 Million - $2.26 Million	-241,139 Reduced 61.0%	154,165 $732,000
Q1 2021 May 17, 2021	BUY	$4.59 - $9.04 $358,818 - $706,692	78,174 Added 24.65%	395,304 $3.29 Million
Q4 2020 Feb 16, 2021	BUY	$1.51 - $6.3 $425,394 - $1.77 Million	281,718 Added 795.54%	317,130 $1.55 Million
Q3 2020 Nov 16, 2020	SELL	$1.7 - $3.28 $46,149 - $89,042	-27,147 Reduced 43.39%	35,412 $60,000
Q2 2020 Aug 14, 2020	SELL	$2.43 - $3.23 $6,607 - $8,782	-2,719 Reduced 4.17%	62,559 $178,000
Q1 2020 May 14, 2020	SELL	$2.49 - $4.39 $7,196 - $12,687	-2,890 Reduced 4.24%	65,278 $191,000
Q4 2019 Feb 14, 2020	SELL	$3.75 - $6.11 $112,706 - $183,636	-30,055 Reduced 30.6%	68,168 $269,000
Q3 2019 Nov 14, 2019	BUY	$3.87 - $6.13 $380,123 - $602,106	98,223 New	98,223 $491,000

Others Institutions Holding ONCT

# of Institutions

Shares Held

362K

Call Options Held

Put Options Held

View Full List

About Oncternal Therapeutics, Inc.

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

More about ONCT

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account